#United States #San Francisco #Darmiyan #BrainSee #DarmiSpace

Darmiyan Joins the Medicare GUIDE Program

Darmiyan, Inc., an innovative player in brain health technology, has proudly announced its involvement in the Medicare's Guiding an Improved Dementia Experience (GUIDE) Model. This initiative aims to enhance the quality of dementia care while supporting caregivers, allowing individuals to maintain a better quality of life in their own homes for an extended period.

Strategic Partnerships

Darmiyan has partnered with a group of respected organizations, including Five Star Home Health Care, CareBrains, and Brain Watch Coalition. By combining their efforts, these entities aim to revolutionize dementia care using advanced technologies like BrainSee and DarmiSpace. These tools are designed to facilitate early risk assessment and preventive measures against cognitive decline, marking a significant step forward in dementia healthcare.

The GUIDE Model

The GUIDE Model, spearheaded by the Centers for Medicare and Medicaid Services (CMS), is an ambitious eight-year initiative that serves nearly 400 healthcare organizations across the country. These include a mix of major medical centers and community-based organizations, collectively working to improve the quality of care for approximately 57 million Americans affected by dementia.

Darmiyan’s Technological Innovations

Darmiyan’s BrainSee is heralded as the first FDA-approved AI-powered prognostic tool that delivers precise prognoses for mild cognitive impairment (MCI) through non-invasive assessments. Alongside this, DarmiSpace functions as a personalized lifestyle management platform that assists in managing care by analyzing BrainSee scores and lifestyle factors to guide preventative interventions.

Johnny Wilkinson, CEO of Five Star Home Health Care, emphasized the importance of combining their efforts with Darmiyan's innovative solutions. He remarked, “Our commitment to providing top-tier dementia care solutions is significantly enhanced by Darmiyan's technologies, which empower our patients to lead healthier, more independent lives.”

Supporting this sentiment, Jodi Lyons, Co-Founder of CareBrains, added, “The accuracy of BrainSee combined with DarmiSpace’s preventative capability allows us to approach cognitive decline with hope and innovative care solutions.”

Expert Perspectives

Dr. Padideh Kamali-Zare, the founder and CEO of Darmiyan, highlighted that combating dementia starts with prevention through early risk assessments and actionable solutions. “This partnership enables healthcare providers to adopt a proactive approach to dementia care, creating a landscape of real hope for countless individuals,” he stated.

Darmiyan also expressed enthusiasm about sharing their groundbreaking tools with other GUIDE awardees, including well-respected institutions like UCSF, UCLA, Emory, Mount Sinai, and Columbia University.

About Darmiyan, Inc.

Founded in 2016 and based out of San Francisco, California, Darmiyan has made strides in the realm of brain health with its innovative products. By combining state-of-the-art technology with advanced neuroscience and artificial intelligence, Darmiyan is at the forefront of addressing cognitive decline with precision. Their commitment to leading the way in brain health solutions positions them as a key partner in the fight against dementia.

In conclusion, Darmiyan's entry into the Medicare GUIDE Program, powered by strategic partnerships and advanced technology, sets a new standard for dementia care, promising improved outcomes for patients and families alike.